Showing results (421-430 of 437) with videos related to

Sort By:
Pageof 44
Pediatric Blood & Cancer|July 22, 2024
Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single-institution study with molecular correlationSteven S Carey, Jie Huang, Jason R Myers, et al.
Gynecologic Oncology|February 1, 2020
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomesStephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Molecular and Cellular Endocrinology|April 22, 2014
MicroRNAs as prognostic markers in ovarian cancerMarta Llauradó, Blanca Majem, Tatiana Altadill, et al.
Molecular Cancer Therapeutics|October 5, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMarta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, et al.
Gynecologic Oncology|August 9, 2023
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinomaNelson K Y Wong, Marta Llaurado Fernandez, Felix K F Kommoss, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
The New England Journal of Medicine|December 30, 2011
A phase 3 trial of bevacizumab in ovarian cancerTimothy J Perren, Ann Marie Swart, Jacobus Pfisterer, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
Pageof 44